MEK Inhibition Enhances Paclitaxel-induced Tumor Apoptosis
Open Access
- 1 December 2000
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 275 (50), 38953-38956
- https://doi.org/10.1074/jbc.c000684200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cellsOncogene, 1999
- VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK SignalingExperimental Cell Research, 1999
- Role of MEKK1 in Cell Survival and Activation of JNK and ERK Pathways Defined by Targeted Gene DisruptionScience, 1998
- In Situ Visualization of Intratumor Growth Factor Signaling: Immunohistochemical Localization of Activated ERK/MAP Kinase in Glial NeoplasmsThe American Journal of Pathology, 1998
- Paclitaxel (Taxol)-induced Gene Expression and Cell Death Are Both Mediated by the Activation of c-Jun NH2-terminal Kinase (JNK/SAPK)Online Journal of Public Health Informatics, 1998
- Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase PathwaysOnline Journal of Public Health Informatics, 1998
- Hyperexpression of mitogen-activated protein kinase in human breast cancer.JCI Insight, 1997
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Paclitaxel (Taxol)The New England Journal of Medicine, 1995
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences of the United States of America, 1980